TA 270

Drug Profile

TA 270

Alternative Names: TA-270

Latest Information Update: 06 Feb 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Dainippon Ink & Chemicals
  • Developer Mariposa Health Limited
  • Class Antiallergics; Antiasthmatics; Quinolones
  • Mechanism of Action 5-lipoxygenase inhibitors; Antioxidants; Free radical scavengers; Immunosuppressants; Leukotriene B4 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Chronic obstructive pulmonary disease

Highest Development Phases

  • Phase II Asthma; Chronic obstructive pulmonary disease
  • Preclinical Cystic fibrosis

Most Recent Events

  • 06 Feb 2018 Preclinical trials in Asthma in Australia (Inhalation) (Mariposa health pipeline, February 2018)
  • 06 Feb 2018 Preclinical trials in Chronic obstructive pulmonary disease in Australia (Inhalation) (Mariposa health pipeline, February 2018)
  • 06 Feb 2018 Preclinical trials in Cystic fibrosis in Australia (Mariposa health pipeline, February 2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top